Lilly, Amylin Analysis Finds No Bydureon Effect on Heart Rhythm

Amylin Pharmaceuticals Inc., Eli Lilly & Co., and Alkermes Inc. said an analysis of a 148-patient trial found no evidence that their experimental Bydureon diabetes drug causes prolonged heart rhythms.
Bloomberg